IRadimed Corporation
IRMD
$51.32
-$0.96-1.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.63% | 5.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.63% | 5.80% | |||
| Cost of Revenue | 0.85% | 11.95% | |||
| Gross Profit | 0.55% | 4.01% | |||
| SG&A Expenses | 4.72% | 8.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.61% | 8.39% | |||
| Operating Income | -6.36% | 0.19% | |||
| Income Before Tax | -6.29% | -1.15% | |||
| Income Tax Expenses | 5.04% | -12.51% | |||
| Earnings from Continuing Operations | -8.93% | 1.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.93% | 1.93% | |||
| EBIT | -6.36% | 0.19% | |||
| EBITDA | -6.16% | 0.14% | |||
| EPS Basic | -9.14% | 1.83% | |||
| Normalized Basic EPS | -6.55% | -1.20% | |||
| EPS Diluted | -8.05% | 0.63% | |||
| Normalized Diluted EPS | -6.46% | -1.34% | |||
| Average Basic Shares Outstanding | 0.24% | 0.11% | |||
| Average Diluted Shares Outstanding | 0.12% | 0.25% | |||
| Dividend Per Share | 0.00% | 13.33% | |||
| Payout Ratio | 0.25% | -0.02% | |||